Industry wants a swift decision on EMA location

24 April 2017 - Deborah Wilkes

Archived

The pharmaceutical industry is calling for a swift decision on the new location of the European Medicines Agency (EMA), following the UK's decision to leave the European Union. The new location must have "world class connectivity", says the industry, which also stresses the importance of retaining "highly competent staff".

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: